JENA MCBRIDE: Open Payments
NPI 1598194508 · DECATUR, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 17 payments from 9 companies in 2025. Trend: 2023 $43 · 2024 $232 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $73 |
| Antares Pharma, Inc. | 4 | $63 |
| Lilly USA, LLC | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Verity Pharmaceuticals Inc. | 1 | $15 |
| TOLMAR, INC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $14 |
Products named: XYOSTED, MOUNJARO, SPRAVATO, Wegovy, Ozempic, Rybelsus, CAPLYTA, VRAYLAR.
Industry payments across TX — which companies pay providers there.
